Related references
Note: Only part of the references are listed.Adipose tissue lymphocytes and macrophages in obesity and insulin resistance -: Makers or markers, and which comes first?
A. Bouloumie et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia
Yasmine S. Ali et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2008)
Secondary prevention of cardiovascular disease in type 2 diabetes and prediabetes: a cardiologist's perspective
R. Cubbon et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Impact of statin therapy on systemic inflammation, left ventricular systolic and diastolic function and prognosis in low risk ischemic heart disease patients without history of congestive heart failure
Hiroyuki Okura et al.
INTERNAL MEDICINE (2007)
Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome
Sridevi Devaraj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Acute-phase serum amyloid A: An inflammatory adipokine and potential link between obesity and its metabolic complications
Rong-Ze Yang et al.
PLOS MEDICINE (2006)
Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus -: Results from a controlled randomized study
MR Langenfeld et al.
CIRCULATION (2005)
Serum amyloid A:: production by human white adipocyte and regulation by obesity and nutrition
C Poitou et al.
DIABETOLOGIA (2005)
Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation
A Hognestad et al.
CLINICAL CARDIOLOGY (2004)
High-density lipoproteins in sepsis and septic shock: Metabolism, actions, and therapeutic applications
AH Wu et al.
SHOCK (2004)
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women - The National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)
BD Johnson et al.
CIRCULATION (2004)
Regulation of the human acute phase serum amyloid a genes by tumour necrosis factor-α, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines
CF Thorn et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
Trends in cardiovascular complications of diabetes
CS Fox et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus
JS Sidhu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study
S Kinlay et al.
CIRCULATION (2003)
Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes
E Leinonen et al.
ATHEROSCLEROSIS (2003)
Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers
MT Magyar et al.
STROKE (2003)
Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease
C Bickel et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation
DH Walter et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
MA Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
T Holm et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
A novel function of serum amyloid A:: A potent stimulus for the release of tumor necrosis factor-α, interleukin-1β, and interleukin-8 by human blood neutrophil
CJ Furlaneto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)